用德克萨米他和布皮瓦卡因进行胸切除术后的疼痛缓解通过周围气:一种随机对照试验
Hamid Talebzadeh1,2, Mohammad Eslamian3,4, Erfan Sheikhbahaei5
1Department of Surgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
BMC anesthesiology
|July 16, 2024
概括
通过周周导管将德克萨米他添加到布皮瓦卡因中,显著减少了胸切除术患者的术后疼痛和住院时间. 这种组合疗法可以改善疼痛管理,并在胸部手术后更快地恢复.
科学领域:
- 麻醉学 麻醉学
- 胸部外科手术 胸部外科手术
- 药理学 药理学是指药理学的学科.
背景情况:
- 胸腔切除手术程序与严重的术后疼痛和潜在的恶心/吐有关.
- 葡萄糖皮质类药物,像甲一样,具有抗炎和神经阻断的特性,表明潜在的止痛和抗益处.
- 胸切除术后优化疼痛管理对于患者的康复和减少医疗保健资源利用至关重要.
研究的目的:
- 为了研究局部德克萨米他与布皮瓦卡因结合的附加止痛作用.
- 为了评估这种组合的疗效,通过周围导管进行治疗,以控制胸腔切除术后的疼痛.
- 评估对术后疼痛,恶心/吐,阿片类药物消耗和住院时间的影响.
主要方法:
- 一项随机对照试验,涉及82名接受胸切除术的患者.
- 参与者通过周围导管接受了bupivacaine与dexamethasone或bupivacaine与盐水安慰剂.
- 主要结局是24小时后的疼痛严重程度 (视觉模拟量表);次要结局包括恶心/吐,阿片类药物使用和停留时间.
主要成果:
- 德克萨米他组在24小时内显示出明显较低的视觉模拟量级疼痛评分 (p < 0.001).
- 术后阿片类药物消耗和住院时间的中位数在德克萨米他组显著减少 (分别为p=0.024和p<0.001).
- 手术后恶心/吐和手术部位感染的发生率在各组之间没有显著差异.
结论:
- 通过周围导管 (peripleural catheter) 局部给药德克萨米他加布皮瓦卡因有效降低胸切除术后的术后疼痛.
- 这种综合治疗方案导致止痛药消耗减少,住院时间缩短.
- 这些发现支持使用德克萨米他作为布皮瓦卡因的辅助剂,以增强胸切除术患者的术后疼痛管理.
相关概念视频
Local Anesthetics: Clinical Application as Epidural Anesthesia
428
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
428
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
386
Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
One of the advantages of...
386
Local Anesthetics: Clinical Application as Spinal Anesthesia
614
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
614
Depolarizing Blockers: Pharmocokinetics
317
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
317
Skeletal Muscle Relaxants: Therapeutic Uses
478
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
478
Pneumothorax-II
135
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
135


